• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18422 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Dupilumab in atopic dermatitis not adequately controlled with atopical therapy]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Ustekinumab in Crohn’s disease]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Ozone therapy]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Radiofrequency ablation in benign bone tumors]
2020     NIHR Health Technology Assessment programme Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic spine surgery for disc disease and lumbar spinal stenosis]
2020     Ontario Health 10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic full-thickness resection of colorectal lesions]
2020     Ontario Health Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020     Austrian Institute for Health Technology Assessment (AIHTA) Home-Treatment in Child and Adolescent Psychiatry: An Analysis of the Effectiveness and Possible Implementation in Austria
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Virtual colonoscopy for colorectal cancer screening in patients with diverticular disease]
2020     Ontario Health Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-arterial chemotherapy for retinoblastoma]
2020     Adelaide Health Technology Assessment (AHTA) Discussion paper on pan-tumour biomarker testing to determine eligibility for targeted treatment.
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Intranasal esketamine for severe resistant major depression]
2020     Ontario Health 5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with yellow fever vaccination
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Intrathecal baclofen pump in spastic patients]
2020     Ontario Health Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with oral cholera vaccination
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Endometrial microbiome test in assisted reproduction]
2020     Ontario Health Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Eculizumab in the management of paroxysmal nocturnal hemoglobinuria and atypical hemolytic-uremic syndrome]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Migalastat for Fabry disease]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: safety of switching biologics and their interchangeability]
2020     Health Technology Wales (HTW) The clinical effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis
2020     NIHR Health Technology Assessment programme Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT
2020     NIHR Health Technology Assessment programme Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study
2020     NIHR Health Technology Assessment programme Dementia Care Mapping to reduce agitation in care home residents with dementia: the EPIC cluster RCT
2020     NIHR Health Services and Delivery Research programme Understanding and improving experiences of care in hospital for people living with dementia, their carers and staff: three systematic reviews
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: update of the systematic review of the effects of palivizumab prophylaxis on reducing complications associated with respiratory syncytial virus infections in children]
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Advice on a potential candidate for conditional inclusion of rhPTH 1-84 (Natpar®) in chronic hypoparathyroidism
2020     NIHR Health Technology Assessment programme Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS advice concerning romosozumab (Evenity®) for the treatment of severe osteoporosis
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of amikacin liposome inhalation suspension (Arikayce® liposomal) for the treatment of NTM lung infections
2020     Austrian Institute for Health Technology Assessment (AIHTA) Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment - extension of further conditions for nintedanib (Ofev®)
2020     NIHR Health Technology Assessment programme Stratified Care for Patients with Sciatica and Suspected Sciatica in Primary Care: a randomised trial (the SCOPiC trial - SCiatica Outcomes in Primary Care)
2020     NIHR Health Technology Assessment programme Medically unexplained symptoms(MUS): primary care intervention
2020     Austrian Institute for Health Technology Assessment (AIHTA) Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Package advice polatuzumab vedotin (Polivy®) in combination with bendamustine and rituximab (Pola-BR) for the treatment of r/r DLBCL
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of tafamidis (Vyndaqel®) for the treatment of wild-type or hereditary transthyretin amyloidosis
2020     NIHR Health Technology Assessment programme A randomised parallel group double blind placebo-controlled dose ranging Trial of low dose adjunctive alTeplase during priMary PCI (T-TIME)
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Advice on a potential candidate for conditional inclusion of ataluren (Translarna®) for Duchenne's muscular dystrophy
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: iStent® and iStent inject® trabecular bypass for micro-invasive glaucoma surgery (MIGS)]
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS advice concerning siponimod (Mayzent®) for the treatment of secondary progressive multiple sclerosis
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Package advice venetoclax (Venclyxto®) in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)
2020     NIHR Health Technology Assessment programme Pre-Operative Behavioural Intervention to Reduce Drinking before elective orthopaedic Surgery (Pre-Op BIRDS)
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes]
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of glucagon nasal powder (Baqsimi®) for the treatment of severe hypoglycaemia
2020     NIHR Health Technology Assessment programme Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
2020     NIHR Health Technology Assessment programme Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis
2020     Center for Evidence-based Practice (CEP) Adverse effects of messenger RNA vaccines
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of ozanimod (Zeposia®) for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS)
2020     NIHR Health Services and Delivery Research programme Identifying appropriate symbol communication aids for children who are non-speaking: enhancing clinical decision making
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec, an evaluation in the real-world context of care, 2013 to 2018]
2020     Center for Evidence-based Practice (CEP) Antibiotic prophylaxis for lower extremity wound debridement in the outpatient setting
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of amisulpride (Aktiprol®) for the treatment of schizophrenia
2020     NIHR Health Technology Assessment programme Surgical fixation compared with cast immobilisation for adults with a bicortical fracture of the scaphoid waist: the SWIFFT RCT
2020     NIHR Health Technology Assessment programme What is the effectiveness of varenicline compared with nicotine replacement therapy for long term smoking cessation and clinically important outcomes such as mortality, myocardial infarction and frequency of service use? Evidence from the Clinical Practice Research Datalink
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: RebinynTM (nonacog beta pegol) – coagulation factor IX (recombinant), notice of inclusion on the Liste des produits du système du sang du Québec]
2020     Center for Evidence-based Practice (CEP) Point of care vascular ultrasound
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Package advice esketamine nasal spray (Spravato®) for the treatment of adults with treatment-resistant major depressive disorder
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: recommendations concerning the information required to monitor nusinersen use in real-world settings]
2020     Center for Evidence-based Practice (CEP) Early mobilization to reduce medical inpatient length of stay and adverse
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Trastuzumab-emtansine (Kadcyla®) in adjuvant treatment of adult patients with HER-2 positive breast cancer in an early stage
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients
2020     NIHR Health Services and Delivery Research programme Identifying nurse-staffing requirements using the Safer Nursing Care Tool. Modelling the costs and consequences of real world application to address variation in patient need on hospital wards
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Advice reassessment osimertinib (Tagrisso®)
2020     NIHR Health Technology Assessment programme Seasonal Influenza Vaccination Effectiveness II (SIVE II): use of a large national primary care and laboratory-linked dataset to evaluate live attenuated and trivalent inactivated influenza vaccination effectiveness
2020     NIHR Public Health Research (PHR) programme Feasibility study of how best to engage obese men in narrative SMS (short message system) and incentive interventions for weight loss, to inform a future effectiveness and cost-effectiveness trial
2020     NIHR Health Technology Assessment programme Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Avelumab in combination with axitinib as a first-line treatment for adult patients with advanced renal cell carcinoma
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of ivacaftor/tezacaftor (Symkevi®) in combination with ivacaftor (Kalydeco®) for the treatment of cystic fibrosis
2020     NIHR Public Health Research (PHR) programme Healthy Dads, Healthy Kids UK: a cultural adaptation and feasibility study of a weight management programme for fathers of younger children
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Ibrutinib (Imbruvica®) for the treatment of Waldenstrom's disease
2020     NIHR Health Services and Delivery Research programme An evaluation of alcohol treatment centres: implications for service delivery, patient benefit and harm reduction
2020     Swiss Federal Office of Public Health (FOPH) Glinides and glitazones in the treatment of type 2 diabetes
2020     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of the macrobiotic diet]
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Ibrutinib (Imbruvica®) for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)
2020     NIHR Health Technology Assessment programme Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of Trifarotene (50 microgram/gram cream) (Aklief®) for the cutaneous treatment of acne vulgaris on the face and torso in patients aged 12 years and over
2020     NIHR Health Technology Assessment programme Examining the benefit of graduated compression stockings as an adjunct to low dose low molecular weight heparin in the prevention of venous thromboembolism in elective surgical inpatients identified as moderate or high risk for venous thromboembolism a multi-centre randomised controlled trial
2020     NIHR Health Services and Delivery Research programme Understanding how frontline staff use patient experience data for service improvement - an exploratory case study evaluation and national survey (US-PEx)
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Package advice dabrafenib/trametinib (Tafinlar®/Mekinist®)
2020     NIHR Health Services and Delivery Research programme Young people with Attention Deficit Hyperactivity Disorder (ADHD) in transition from children's services to adult services (Catch-uS): a mixed methods project using national surveillance, qualitative and mapping studies
2020     Norwegian Institute of Public Health (NIPH) [Hyperbaric oxygen therapy for radiation-induced cystitis]
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of oral semaglutide (Rybelsus®)
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Pentosan polysulfate sodium (Elmiron®) for the treatment of bladder pain syndrome characterized by either glomerulations or Hunner’s lesions
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) 12 SQ-HDM SLIT (Itulazax®) for the treatment of allergic rhinitis or conjunctivitis induced by pollen from the birch homologous group
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Olaparib (Lynparza®) for the maintenance treatment of adult patients with carcinoma of the ovaries, tubes or peritoneum (package advice)
2020     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Pharmacological treatment of common pain conditions in older persons]
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Trientine tetrahydrochloride (Cuprior®) [for] the treatment of Wilson's disease
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) GVS assessment of hydroquinine (Inhibin®) for patients with nocturnal muscle cramps
2020     European Network for Health Technology Assessment (EUnetHTA) Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for haematopoietic stem cell transplant
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations (package advice)
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Bevespi® aerosphere 7.2 micrograms / 5 micrograms
2020     European Network for Health Technology Assessment (EUnetHTA) Siponimod for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity
2020     NIHR Health Services and Delivery Research programme Patient Experience And Reflective Learning (PEARL)
2020     European Network for Health Technology Assessment (EUnetHTA) Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)